adriamycin-induced nephrotic syndrome. Nephrotic syndrome is associated with abnormal regulation of renal water excretion. To investigate the role of collecting duct water channels and solute transporters in this process, we have carried out semiquantitative immunoblotting of kidney tissues from rats with adriamycin-induced nephrotic syndrome. These experiments demonstrated that adriamycin-induced nephrotic syndrome is associated with marked decreases in expression of aquaporin-2, aquaporin-3, aquaporin-4, and the vasopressin-regulated urea transporter in renal inner medulla, indicative of a suppression of the capacity for water and urea absorption by the inner medullary collecting duct. In contrast, expression of the ␣ 1 -subunit of the Na,K-ATPase in the inner medulla was unaltered. Light and electron microscopy of perfusion-fixed kidneys demonstrated that the collecting ducts are morphologically normal and unobstructed. Inner medullary expression of the descending limb water channel, aquaporin-1, was not significantly altered, pointing to a selective effect on the collecting duct. Aquaporin-2 and aquaporin-3 expression was also markedly diminished in the renal cortex, indicating that the effect is not limited to the inner medullary collecting duct. Differential centrifugation studies and immunocytochemistry in inner medullary thin sections demonstrated increased targeting of aquaporin-2 to the plasma membrane, consistent with the expected short-term action of vasopressin on aquaporin-2 trafficking. The extensive down-regulation of aquaporin and urea transporter expression may represent an appropriate renal response to the extracellular volume expansion observed in nephrotic syndrome, but may occur at the expense of decreased urinary concentrating and diluting capacity.
The kidney plays a central role in the regulation of body salt and water balance. Disordered regulation of transport in the kidney is responsible for altered salt and water balance in several pathophysiological states including the nephrotic syndrome. Regulation of salt and water excretion depends on an array of solute and water transporters in renal tubules and vascular elements in the various regions of the kidney [1] . Recent progress in cloning of cDNAs for many of these transporters has made it possible to prepare specific antibodies that can be used to investigate physiological and pathophysiological mechanisms [2] . Using these antibodies, several transporter proteins important for the regulation of water excretion have recently been characterized. One example is the vasopressin-regulated urea transporter, which mediates the exit of urea from the inner medullary collecting duct, a process that is critical for the accumulation of urea in the inner medullary interstitium and the generation of a corticomedullary osmolality gradient [3] . Also important in the regulation of renal water excretion are the aquaporin water channels. Aquaporins are a newly recognized family of transmembrane proteins that function as molecular water channels [4] . Four aquaporins (aquaporin-1, -2, -3 and -4) are known to be expressed in the kidney where they mediate osmotic water transport across water-permeable epithelia and play critical roles in the concentrating and diluting process. Aquaporin-1 is expressed in the proximal tubule and descending limb of Henle's loop, while aquaporin-2, -3 and -4 are expressed in the collecting duct system.
Aquaporin-2 is recognized as the "vasopressin-regulated water channel." Vasopressin regulates aquaporin-2 in two ways. It has a short-term effect to trigger translocation of aquaporin-2-containing intracellular vesicles to the apical plasma membrane, thus increasing principal cell water permeability [5] [6] [7] . In addition, vasopressin has a long-term effect to increase the abundance of aquaporin-2 in collecting duct principal cells, increasing the maximally attainable water permeability [8 -10] . Furthermore, long term antidiuresis is associated with increased abundance of the basolateral water channel aquaporin-3 [10, 11] .
Several diseases characterized by extracellular fluid volume expansion are associated with excessive renal salt and water reabsorption, such as congestive heart failure, hepatic cirrhosis, and nephrotic syndrome. The mechanisms of salt and water retention in these process are incompletely understood, but can be expected to be associated in part with abnormal regulation of renal solute and water transporters. For example, it has been demonstrated in congestive heart failure rats with hyponatremia that the abundance of aquaporin-2 is markedly increased, providing a probable explanation for the excess of free water reabsorption in this state [12, 13] . Furthermore, rat models of hepatic cirrhosis have suggested a similar picture with an increase in aquaporin-2 expression in the kidney [14, 15] . In contrast, a completely different picture has been observed with a rat model of nephrotic syndrome [16] . Specifically, puromycin aminonucleoside (PAN)-induced nephrotic syndrome in rats was found to be associated with a marked decrease in the expression of aquaporin-2 and aquaporin-3 in the inner medulla, which could be considered a physiologically appropriate kidney response to systemic water retention. Although this study provided new data important to the understanding of the pathophysiology of nephrotic syndrome, several questions remain to be addressed.
The present study had several objectives. First, we wished to investigate whether the decrease in aquaporin expression in the inner medulla seen previously in PAN-nephrotic syndrome is unique to PAN model or could be a more general characteristic of the nephrotic syndrome. To address this question we set up a different model of nephrotic syndrome, namely, the adriamycininduced nephrotic syndrome [17] . Second, to address whether the down-regulation of aquaporin expression is unique to the medullary portion of the collecting duct, we investigated the expression of water channels in both cortex and medulla. Third, we investigated whether the suppression of transporter expression was limited to water channels or includes collecting duct solute transporters.
METHODS

Antibodies
Polyclonal antibodies prepared against aquaporin-1 [10] , aquaporin-2 [9] , aquaporin-3 [11], aquaporin-4 [18] , and vasopressinregulated urea transporter [3] have been described previously. They were raised against carrier-conjugated synthetic peptides corresponding to the carboxyl terminal tails of each of the proteins. The specificity of each has been demonstrated by showing unique peptide-abatable bands on immunoblots and a unique distribution of labeling by immunohistochemistry and immunoelectron microscopy. All of these antibodies were affinity purified against the immunizing peptides for use in these studies.
Antibodies against the heterotrimeric G-protein subunit G s ␣ [19] and the adenylyl cyclase isotype VI (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were also used. In addition, mouse monoclonal antibodies against the Na,K-ATPase ␣1 subunit (Upstate Biotechnology, Lake Placid, NY, USA) and against the heat shock protein Hsp-70 (Stressgen, Victoria, B.C., Canada) were employed.
Animal model
Pathogen-free male Sprague-Dawley rats (National Cancer Institute Breeding Facility, Frederick, MD, USA; body wt 200 to 300 g) were used in this study. These rats were maintained initially in filter-top microisolator cages with autoclaved food and bedding, and were allowed free access to drinking water all the times. After equilibration in metabolism cages, the animals were briefly anesthetized by inhalation of Metofane and were injected intravenously through the femoral vein adriamycin with 7.5 mg/kg weight (doxorubicin hydrochloride; Sigma, St. Louis, MO, USA) dissolved in sterile normal saline, or were injected with the vehicle alone. The rats were subsequently maintained in the metabolism cages to allow urine collections. Three set of animals were studied, two for immunochemical approaches and the other one for morphological analysis.
The animals were killed by decapitation and blood was collected from the neck. Serum was separated and saved at Ϫ20°C for analysis. The urine voided over the 12 hours period immediately preceding death of the animals was also collected and saved for analysis.
All animal experimentation described in this article was conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NHLBI/IR protocol number 5-KE-1).
Blood and urine analysis
Urine and serum osmolalities were measured using a vapor pressure osmometer (Model 5100C; Wescor, Logan, UT, USA). Urine and serum proteins were measured by using bicinchoninic acid (BCA) protein assay reagent (Pierce, Rockford, IL, USA). Serum cholesterol and triglycerides were measurement by enzymatic reaction (Kits 352-20 and 330-10, respectively; Sigma). Urine and serum sodium were also determined by flame photometry. Creatinine levels in urine and serum samples were quantified colorimetrically (alkaline picrate method, Kit no. 555-A; Sigma Diagnostics). The clearance of creatinine (C Cr ) was determined by the formula C Cr ϭ V ϫ (U/P) Cr , where V is the volume flow of urine (ml/min) voided in a given collection and (U/P) Cr is the ratio of the concentration of creatinine in urine to that in serum. In addition, intraperitoneal fluid volume was quantified in each rat by collecting the fluid into pre-weighed 50 ml centrifuge tubes and reweighing the tubes. The samples were collected by aspiration from the opened peritoneal cavity with a syringe followed by adsorption of the remaining fluid with gauze sponges. The sponges were included in the centrifuge tubes when they were preweighed so that the difference in weight represented the weight of the collected peritoneal fluid. Peritoneal fluid volumes in ml were then calculated assuming that the intraperitoneal fluid has a density of 1.0.
Kidney dissection and tissue preparation for immunoblotting
After killing the rats, both kidneys were rapidly removed and washed briefly in isotonic saline. The left kidneys were dissected to obtain inner medulla and cortex. The tissue was initially homogenized for 15 seconds using a tissue homogenizer (Omni 1000 fitted with a micro-sawtooth generator) in ice-cold isolation solution containing 250 mM sucrose/10 mM triethanolamine (Calbiochem, La Jolla, CA, USA) with 1 g/ml leupeptin (Bachem California, Torrance, CA, USA) and 0.1 mg/ml phenylmethyl sulfonyl fluoride (United States Biochemical Corporation, Toledo, OH, USA). The total protein concentration in each sample was measured using the Pierce BCA protein assay reagent kit.
The right kidneys were homogenized and differential centrifugation was carried out as follows. The whole kidney homogenate from the right kidneys were centrifuged at 1000 ϫ g for ten minutes to remove nuclei and incompletely homogenized membrane fragments. To increase yield, this pellet was rehomogenized as described above and was spun again at 1000 ϫ g for 10 minutes. The supernatants from the two 1000 ϫ g centrifugations were pooled to give the "post-nuclear supernatant." The post-nuclear supernatant was subjected to two subsequent centrifugations. To obtain a plasma membrane-enriched fraction [20] , the pooled supernatant was centrifuged at 17,000 ϫ g for 20 minutes. Then, the supernatant from the 17,000 ϫ g centrifugation was spun to 200,000 ϫ g for 60 minutes to obtain a vesicle-enriched fraction [20] . The 1000 ϫ g and 17,000 ϫ g centrifugations were carried out using a Sorvall RC2-B refrigerated centrifuge with a SS-34 rotor (DuPont Medical Products, Newtown, CT, USA). The 200,000 ϫ g spin was carried out with a Beckman L8-M ultracentrifuge fitted with a type 80TI rotor. The resulting pellets were resuspended in isolation solution and total protein concentration in membrane fraction was measured using the Pierce BCA Protein Assay reagent kit prior to addition of Laemmli sample buffer for immunoblotting.
Electrophoresis and immunoblotting of membrane proteins
The membranes were solubilized at 60°C for 15 minutes in Laemmli sample buffer. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed on 6% or 12% polyacrylamide. For each set of samples from vehicle treated control rats and adriamycin-treated rats, an initial gel was stained with Coomassie blue to confirm that equal loading had been achieved as described previously [10] . Representative bands were quantified by laser densitometry (Personal Densitometer SI; Molecular Dynamics, San Jose, CA, USA), assuring that loading did not differ for any sample by more than 10% from the mean. For immunoblotting, the proteins were transferred from unstained gels electrophoretically to nitrocellulose membranes. After being blocked with 5 g/dl nonfat dry milk for 30 minutes, the blots were probed with the respective antibodies, for 24 hours at 4°C. After washing, the nitrocellulose membranes were exposed to secondary antibody (donkey anti-rabbit immunoglobulin G conjugated with horseradish peroxidase, Pierce no. 31458, diluted 1:5000, or goat antimouse IgG conjugated with horseradish peroxidase, Pierce no. 31434, diluted 1:5000) for one hour at room temperature. Sites of antibody-antigen reaction were visualized using luminol-based enhanced chemiluminescence (Supersignal Substrate for Western blotting, Pierce no. 34080). The blots were quantitated by densitometry (Molecular Dynamics Model PDS1-P90 with Image-QuaNT v4.2 software).
Electron microscopy of renal tissue
The kidneys from control and adriamycin-treated rats were preserved for transmission electron microscopy by vascular perfusion fixation. The rats were anesthetized with Inactin (Thiobutalbarbital, 100 mg/kg body wt, intraperitoneally) and a laparotomy was performed. The abdominal aorta was cannulated below the renal arteries and, after the vena cava was severed, a physiological saline solution (37°C) was perfused though the kidney at a pressure of 140 mm Hg. After the kidneys were cleared of blood and without interruption of perfusion pressure, a phosphatebuffered 2% glutaraldehyde solution (pH 7.2, 410 mOsm) was perfused through the kidneys for approximately three minutes. Following perfusion fixation, the samples were immersed in phosphate-buffered 2% glutaraldehyde overnight. For electron microscopy, the fixed kidneys were cut into small blocks, postfixed in 2% osmium tetroxide for one hour, stained in 2% aqueous uranyl acetate for three hours at room temperature, dehydrated through graded acetones and embedded in Spurr medium. Ultrathin sections (50 to 80 nm) were post-stained with uranyl acetate and lead citrate and viewed in JEOL 1200 EX electron microscope (JEOL U.S.A., Peadody, MA) operating at 60 or 80 kV.
Immunocytochemistry
Kidneys from adriamycin-treated and control rats were fixed by vascular perfusion through the abdominal aorta as described above except that the fixative was 4% paraformaldehyde in 0.1 M sodium cacodylate buffer, pH 7.2. The kidneys were post-fixed in the same solution for two hours and then stored in 0.1 M cacodylate buffer, pH 7.2 at 4°C. Tissue blocks were prepared from cortex, outer medulla and from different levels of the inner medulla. The blocks were infiltrated for 30 minutes with 2.3 M sucrose containing 2% paraformaldehyde, mounted on holders and rapidly frozen in liquid nitrogen, essentially as described previously [8] . The frozen tissue blocks were cryosectioned for immunohistochemistry.
Affinity-purified polyclonal anti-aquaporin-2 (L127) was used at 0.1 to 0.3 g/ml. Cryosections of thickness approximately 0.8 m were obtained with a Reichert Ultracut S Cryo-ultramicrotome and were placed on gelatin-coated glass slides. After preincubation with phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA) or 0.1% skimmed milk and 0.05 M glycine for five minutes, the sections were incubated overnight at 4°C with the primary antibody diluted in PBS with 0.1% BSA or 0.1% skimmed milk.
The labeling was visualized by incubation for one hour at room temperature with HRP-conjugated secondary antibody (P448 1:100; DAKO, Glostrup, Denmark), followed by incubation with diaminobenzidine for 10 minutes. Sections were counterstained with Meier counterstain. The following controls were performed: (1) The primary antibody was substituted with non-immune rabbit IgG purified on a protein A column. (2) Adsorption controls carried out by incubation with affinity purified anti-aquaporin-2 previously reacted with the immunizing peptide. (3) Incubations were carried out without use of primary antibody, or without primary and secondary antibody. All controls revealed a complete absence of labeling as previously documented [8] .
Presentation of data and statistical analyses
Quantitative data are presented as mean Ϯ standard error of mean (SEM). Statistical comparisons were accomplished by an unpaired t-test (when variance were the same) or by the Mann-Whitney rank-sum test (when variances were significantly different between groups). P values less than 0.05 were considered as indicating statistical significance.
RESULTS
Whole animal data
Characterization of the nephrotic syndrome induced by adriamycin. All adriamycin-treated rats developed nephrotic syndrome with marked proteinuria, hyperlipidemia and ascites ( Table 1 ). The proteinuria started on day 5 after the injection of adriamycin and rose to its highest levels on the final day before sacrifice (Day 19, Table 1 ). The adriamycin-treated rats developed elevated serum cholesterol and triglyceride levels, cardinal features of the nephrotic syndrome. The quantity of intraperitoneal fluid (Methods) in adriamycin-treated rats (5.4 Ϯ 3.1 ml) was significantly greater than in vehicle-treated rats (0.1 Ϯ 0.01 ml). Cardiac weight normalized by body wt (g heart wt/g body wt) was similar in both groups (adriamycin-treated rats, 0.0033 Ϯ 0.0001; control rats, 0.0037 Ϯ 0.0002). Thus, we conclude that the adriamycintreated rats had fully-developed nephrotic syndrome with extracellular fluid volume expansion at the time that they were killed for analysis of renal transporter expression.
Renal function. Table 2 summarizes urinary and serum values in adriamycin-treated and vehicle-treated rats. Urinary volume and osmolality were not significantly different between the two groups. However, urinary sodium concentration was significantly lower in the adriamycin-treated animals. Indeed, the rate of urinary sodium excretion (not shown in Table 2 ) was markedly decreased in adriamycin-nephrotic rats (81.2 nmol/min) compared to the controls (600 nmol/min). Neither serum sodium nor osmolality were significantly different between the two groups. The clearance of endogenous creatinine at the end of the experimental period was not significantly different between the two groups of rats, although the mean was nominally lower in the adriamycin-treated group ( Table 2) .
Aquaporin expression
Collecting duct aquaporin expression. Figure 1 shows immunoblots comparing aquaporin-2 protein expression levels in nephrotic and control rats. Each lane was loaded with a sample from a different rat. Equal loading among lanes was confirmed by Coomassie staining of SDS-PAGE gels run in parallel with the gel used for immunoblotting. In both cortex and medulla, two bands were observed as demonstrated previously [8, 9] , namely, a sharp band at 29 kDa due to the presence of nonglycosylated aquaporin-2 and a broad band representing the glycosylated form of the protein. There was a striking decrease in aquaporin-2 expression in inner medulla in the nephrotic rats (Fig. 1, top) , similar to the observation previously made in rats with PAN-induced nephrotic syndrome [16] . In addition, Figure 1 shows that this effect was not limited to the medulla, but was also seen in cortex. The densitometric analysis of these blots is summarized in Table 3 . In the inner medulla, the aquaporin-2 band density for adriamycinnephrotic rats averaged 18% of the mean for control rats, whereas in the cortex a smaller decrease was seen. Figure 2 shows results from the same animals using the anti-aquaporin-3 antibody. Two bands were observed as demonstrated previously [11], a sharp band at 27 kDa representing the nonglycosylated protein, and a broader, higher molecular weight band representing the glycosylated protein. As seen with PANinduced nephrotic syndrome [16] , there was a decrease in aquaporin-3 expression in inner medulla of adriamycin-nephrotic rats (Fig. 2, top) . As seen with aquaporin-2, this decrease was not limited to the inner medulla and, in fact, there was a marked decrease in aquaporin-3 expression in cortex (Fig. 2, bottom) . As Table 3 for densitometric analysis. 
Values represent results in nephrotic rats expressed as a percent of the mean for vehicle controls. Results are expressed as mean Ϯ SEM. a P Ͻ 0.05, b P Ͻ 0.01 vs. control rats.
Fernández-Llama et al: Aquaporin and urea transporter in NS summarized in Table 3 , aquaporin-3 band density was decreased to 18% of control levels in the inner medulla and to 33% of control levels in the cortex. Finally, the expression of aquaporin-4, a second water channel expressed in the basolateral membrane of collecting ducts [18] was also assessed by immunoblotting. Aquaporin-4 expression is only detectable in the medulla and there are two bands (31 kDa and 52 kDa) as previously reported [18] . Inner medullary aquaporin-4 expression was significantly decreased in the nephrotic rats compared to vehicle-injected rats ( Fig. 3 and Table 3 ).
Aquaporin-1 expression. Aquaporin-1 is expressed in the proximal tubule in the renal cortex and descending limb of Henle's loop in the renal medulla [4] . Figure 4 shows aquaporin-1 immunoblots for nephrotic and vehicle-infused control rats. There are two bands, one at 28 kDa and a second one broad band at ϳ 35 kDa normally seen for aquaporin-1 in the kidney [10] . In contrast to the collecting duct water channels, there was no significant decrease in aquaporin-1 expression in the inner medulla ( Fig. 4, top) . However, the nephrotic rats displayed a significant decrease in aquaporin-1 expression in the cortex (Fig.  4, bottom and Table 3 ). Thus, proximal tubular expression of aquaporin-1 is affected by the nephrotic state while descending limb expression is not. The cause of the moderate decrease in proximal aquaporin-1 expression cannot be ascertained from the present data. Conceivably, the decrease could be due to atrophy of some of the proximal tubules due to occlusion by casts. Figure 5 (top) shows an immunoblot probed with our antibody to the vasopressin-regulated urea transporter. This transporter is responsible for facilitated urea transport across the apical plasma membrane of inner medullary collecting ducts cells [3] . On this blot made from a 6% polyacrylamide gel, the major isoform runs at approximately 83 kDa. As can be seen in Figure 5 , the expression level of the vasopressin-regulated urea transporter was strikingly decreased in inner medullas from adriamycin-nephrotic rats compared with vehicle-infused controls. As shown in Table 3 , the band density for the vasopressin-regulated urea transporter protein was decreased in adriamycin nephrotic rats to 7% of control levels in the inner medulla. A second band, which runs at approximately 117 kDa, corresponds to a urea transporter protein Table 3 for densitometric analysis. Membrane samples were from the same rats as those used for Figure 1 .
Expression of solute transporters in inner medulla
Fig. 3. Immunoblot comparing expression of aquaporin-4 in inner medullas of vehicle-treated control rats and adriamycin-nephrotic rats.
Each lane was loaded with a sample from a different rat. Ten g of total protein was loaded onto each lane. Membranes samples were from the same rats as those used for Figure 1 . See Table 3 for densitometric analysis. Table 3 for densitometric analysis. Table 3 for densitometric analysis.
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expressed in the inner medullary collecting duct (IMCD) that is believed to be a modified form of the vasopressin-regulated urea transporter, possibly a result of glycosylation at a site upstream from the primary glycosylation site [21] . Figure 5 (bottom) shows an immunoblot, from the same rats, probed with a monoclonal antibody to the Na,K-ATPase ␣1 subunit. The Na,K-ATPase ␣1 subunit protein in the rat has 1018 amino acids [22] and this antibody recognizes a band at close to the expected molecular weight for this protein (ϳ100 kDa). In contrast to the aquaporins and urea transporters, there were no changes in Na,K-ATPase ␣1 subunit expression in the inner medullas of adriamycin-nephrotic rats relative to vehicle-treated controls. As summarized in Table 3 , the band density for Na,K-ATPase in nephrotic rats was 90% of control in the inner medulla. Figure 6 shows immunoblots for three regulatory proteins expressed in the inner medullary collecting duct, viz. the ␣ subunit of the heterotrimeric G-protein G s (G s ␣), adenylyl cyclase VI and stress-inducible heat shock protein of 70 kDa (HSP-70), carried out to determine whether their expression is altered in adriamycin-induced nephrotic syndrome. The anti-G s ␣ antibody recognizes a doublet at 50 kDa and 45 kDa [19] . There was a significant decrease in G s ␣ protein expression in the inner medullas from nephrotic rats (Fig. 6, top) . Band density for adriamycin-nephrotic rats was decreased to 25% of control levels in the inner medulla (Table 3 ). Figure 6 (middle) shows an immunoblot for type VI adenylyl cyclase in inner medullas of nephrotic and control rats. Type VI is the major isoform expressed in collecting duct [23] . In rat, it is a 1180 amino acid integral membrane protein [24] that is presumably glycosylated. The antibody recognizes a broad band around 160 kDa, consistent with the expected size of the protein. As seen in Figure 6 , there was a striking decrease in adenylyl cyclase VI expression in inner medullas of nephrotic rats relative to controls.
Expression of selected regulatory proteins in the inner medulla
The band density was decreased to 12% of control levels in the inner medulla (Table 3 ). Figure 6 (bottom) shows an immunoblot probed an antibody to the heat shock protein HSP-70, a protein involved in the cellular response to various forms of cell stress [25] . In contrast to the other two signaling proteins examined, there was no significant change in the expression of the HSP-70 in inner medullas of nephrotic relative to control rats. Figure 7 shows representative electron microscopic views of medullary collecting ducts from vehicle-treated ( Fig. 7A ) and adriamycin-treated rats (Fig. 7B) 17 days following treatment. The cells lining the medullary collecting ducts of adriamycin-nephrotic rats are normal in appearance with their normal complement of intracellular organelles. However, as in our previous study of the medullary collecting ducts in the PAN model of nephrotic syndrome [16] , enlarged intercellular spaces are evident. We previously demonstrated that the enlargement of intercellular spaces are artifacts resulting from high interstitial pressure during the perfusion fixation of the kidneys, since they are not seen following immersion fixation. (Interspace expansion is not seen in vehicle controls, presumably because collecting duct water permeability is Table 3 for densitometric analysis.
Morphological observations
Fig. 7. Transmission electron micrographs of inner medullary collecting ducts. (A)
Thin section through inner medullary collecting duct cells from a vehicle-treated control rat kidney. The cells exhibit relatively straight intercellular borders, distinct apical junctional complexes (small arrows) and a paucity of cytoplasmic organelles (N is nucleus. ϫ3,500). (B) Thin section through inner collecting duct cells from nephrotic rat, seventeen days following treatment with adriamycin. Other than the presence of distended intercellular spaces due to perfusion fixation (asterisks), the collecting duct cells appear normal, that is, similar to inner collecting duct cells from control rats. The small arrows indicate tight junctions (N is nucleus. ϫ3,500).
high enough in the control state to allow a secretory transepithelial water flux to vent the high pressure in the interstitium [16] .)
Cellular distribution of aquaporin-2
We carried out differential centrifugation experiments and immunocytochemistry to assess the distribution of aquaporin-2 within the collecting duct principal cells in nephrotic kidneys, with a view toward determining whether there is substantial impairment of aquaporin-2 trafficking to the plasma membrane. Figure  8 shows immunoblots from differential centrifugation experiments comparing aquaporin-2 content in the vesicle-enriched fraction (200,000 ϫg pellet from 17,000 ϫ g supernatant) to the aquaporin-2 content in the plasma membrane-enriched fraction (17,000 ϫg pellet). Densitometric analysis of these results demonstrated a statistically significant redistribution of aquaporin-2 (ratio of band density of 17,000 ϫ g fraction to 200,000 ϫ g fraction: control rats, 0.09 Ϯ 0.02; adriamycin-nephrotic rats, 0.27 Ϯ 0.05; P Ͻ 0.01). Thus, in collecting ducts from nephrotic rats, a greater fraction of the total aquaporin-2 was present in the plasma-membrane-enriched fraction.
The results from differential centrifugation experiments were confirmed by immunoperoxidase immunocytochemistry of inner medullary thin sections ( Fig. 9 ). As expected from the immunoblotting results, there was a marked decrease in the intensity of the aquaporin-2 labeling in inner medullary collecting ducts from adriamycin-nephrotic rats compared to controls. However, the residual aquaporin-2 can be seen to be located chiefly in the apical region of the principal cells, suggesting that trafficking mechanisms that deliver aquaporin-2 to the plasma membrane are probably intact.
DISCUSSION
In the work presented here, we used the adriamycin model of nephrotic syndrome to determine whether there is altered expression of collecting duct water and solute transporters associated with the nephrotic syndrome. The adriamycin-treated rats developed heavy proteinuria, marked ascites, and hyperlipidemia, indicative of development of full-blown nephrotic syndrome. The immunoblotting results (Figs. 1 to 3) showed a marked decrease in the expression of all three collecting duct water channels, viz. aquaporin-2, -3, and -4, in the nephrotic rats. The finding of a marked suppression of aquaporin-2 and aquaporin-3 expression in the inner medullary collecting duct is consistent with the results of our previous study of the nephrotic syndrome in which we used a different means of inducing the nephrotic state, namely, puromycin aminonucleoside (PAN) injection [16] . These findings suggest that down-regulation of aquaporin-2 and aquaporin-3 is a feature of nephrotic syndrome per se rather than being an idiosyncrasy of any particular model. Possibly the suppression of aquaporin expression in the collecting ducts of nephrotic animals is an indirect consequence of the brisk proteinuria seen in both models, although the cellular mechanisms involved were not investigated in this study.
It is also conceivable that the down-regulation of aquaporin-2 and aquaporin-3 expression was a result of direct effects of PAN and adriamycin on collecting duct cells, rather than an effect of the nephrotic syndrome per se. The mechanism whereby these agents induce loss of the foot processes of glomerular visceral epithelial cells is unknown, but presumably involves a loss of normal targeting of the vesicular traffic involved in maintaining complex cell shape in these cells. Conceivably, the decline in aquaporin expression could be a consequence of inefficient targeting in collecting duct cells resulting in increased degradation of the proteins. Further studies are necessary to address this issue.
To determine if the decrease in expression of aquaporin water channels is limited to the medullary part of the collecting duct or may be seen throughout the collecting duct system, immunoblotting was done with cortical samples as well as medullary samples. As shown in Figures 1 and 2 , the decrease in the collecting duct water channel abundance (aquaporin-2 and -3) in adriamycininduced nephrotic syndrome was seen in cortex as well as medulla.
(Because aquaporin-4 is not normally expressed in the cortical part of the collecting duct in substantial quantities [18] , we could not evaluate whether it is suppressed there.) These observations therefore suggest that there is a general decrease in aquaporin-2 and aquaporin-3 expression throughout the collecting duct system. Thus, these results rule out mechanisms that would be unique to the inner medulla, such as effect of prostaglandins elaborated from medullary interstitial cells or effects of changes in interstitial osmolality.
The present study demonstrates that the suppression of transporter expression is not limited to water channels, but also includes a solute transporter expressed in the inner medullary collecting duct, namely the vasopressin-regulated urea transporter. This transporter is important to the urinary concentrating mechanism because it supplies urea to the inner medullary interstitium and therefore is responsible for the corticomedullary urea gradient [26] . Thus, suppression of vasopressin-regulated urea transporter expression may contribute to the concentrating defect seen in nephrotic syndrome. Examination of Coomassiestained gels of inner medullary proteins (not shown) indicated that the expression levels of most major proteins in the inner medulla were unchanged in the adriamycin-nephrotic syndrome animals relative to controls. Examples of specific proteins whose expression levels were not suppressed in the inner medullas of nephrotic rats are the ␣-1 subunit of Na,K-ATPase ( Fig. 5 ) and the heat shock protein HSP-70 ( Fig. 6) . Thus, the down-regulation of transporter protein expression appears to be relatively selective. Other pathophysiological states have been demonstrated to manifest a down-regulation of aquaporin-2 expression, viz. lithium-induced nephrogenic diabetes insipidus (NDI) [27] , hypokalemia-induced NDI [28] , and ureteral obstruction [29] . We postulate that similar or identical mechanisms could be involved in the down-regulation seen in all of these entities including nephrotic syndrome. Further studies will be required to address this possibility.
The nephrotic syndrome is characterized by an extracellular volume expansion due to renal sodium and water retention. The finding that the collecting duct water transport pathways are down-regulated is consistently with the generally held view that the maintenance of water retention is not dependent on increased water reabsorption in the collecting duct, but rather depends on increased NaCl absorption along the nephron. Indeed, we spec-ulate that the down-regulation of aquaporin-2 expression could represent a physiologically appropriate response to extracellular volume expansion, perhaps similar to the suppression of aquaporin-2 that accounts for the vasopressin-escape phenomenon [30] . The price that the kidney must pay for this physiologically appropriate down-regulation would be a decrease in urinary concentrating and diluting capacity and hence a limitation in the ability to maintain water balance with extremes of free water intake. Indeed, both urinary concentration and dilution has been shown to be reduced in nephrotic syndrome [reviewed in 16] . Presumably, renal salt and water retention in this model of nephrotic syndrome depends on some combination of increased NaCl and water reabsorption in earlier segments, and perhaps to some extent on reduced glomerular filtration rate. In the present study, although creatinine clearance was not significantly decreased in adriamycin nephrotic rats there was a nominal difference in the mean, suggesting that there may have been some reduction in glomerular filtration rate not detectable with our methods.
The down-regulation of collecting duct water and urea transporter expression in the adriamycin-induced nephrotic syndrome is not a result of disruption of cell integrity or a perceptible rearrangement of cell architecture (Fig. 7) . In the present study, like in the previous study of PAN-induced nephrotic syndrome, transporter down-regulation occurred despite the fact that the collecting duct cells were morphologically normal as demonstrated both by light microscopy and electron microscopy. This finding suggests that the down-regulation does not depend on disruption of normal cell architecture. Furthermore, the collecting duct did not show any evidence of local obstruction due to casts, in contrast to what was seen in proximal tubules and distal nephron segments. Presumably, the lack of obstructive changes in the collecting duct is owing to the branching architecture of the collecting duct system.
The chief factor responsible for the regulation of renal water excretion in the normal state is vasopressin. Circulating vasopressin levels were demonstrated to be increased in PAN-induced nephrotic syndrome in rats, and are presumably increased in adriamycin-induced nephrotic syndrome as well. The vasopressin receptor responsible for the regulation of water permeability in the collecting duct is the so-called V2 receptor. This receptor is an integral membrane protein coupled to adenylyl cyclase through the heterotrimeric G protein G s . Receptor occupation increases intracellular cyclic AMP levels in collecting duct cells through activation adenylyl cyclase [31] . Elevated cyclic AMP levels increase the water permeability of the kidney collecting duct in two separate ways [2] . "Short-term" regulation occurs as a result of the ability of cyclic AMP to trigger the fusion of aquaporin-2 containing intracytoplasmic vesicles with the apical plasma membrane, resulting in an increase in the number of apical water channels and consequently an increase in water permeability. "Long-term" regulation is an adaptive increase in collecting duct water permeability that results from an absolute increase in the number of aquaporin-2 water channels in collecting duct principal cells. This response is believed to be in part a result of transcriptional regulation mediated by phosphorylation of cyclic AMP response element (CRE)-binding protein (CREB) and binding of phospho-CREB to a cyclic AMP regulatory element (CRE) in the 5Ј flanking region of the aquaporin-2 gene [32] . The present study shows substantial decreases in the expression levels of G s ␣ and adenylyl cyclase VI in the inner medulla of adriamycin-induced nephrotic rats. Such decreases could theoretically result in decreases in cellular cyclic AMP levels. Therefore, they raise the possibility that the demonstrated decrease in aquaporin-2 expression in the inner medulla of nephrotic rats is a result of chronically decreased intracellular cAMP levels. This possibility remains untested presently. There is evidence from the prior studies with PAN-induced nephrotic syndrome [16] and the present studies ( Figs. 8 and 9 ) that the nephrotic syndrome is associated with an activation of the short-term regulation of aquaporin-2 with increased trafficking of aquaporin-2 to the plasma membrane. This result is seemingly in contradiction with the view that cyclic AMP levels may be suppressed. However, the short-term regulation of water permeability is more complex than generally recognized and may involve regulation of both exocytosis and endocytosis of aquaporin-2, possibly via multiple signaling pathways [33, 34] . Thus, studies of alterations in both cyclic AMP and non-cyclic AMP mediated intracellular signaling seem to be warranted in rat models of nephrotic syndrome.
In summary, adriamycin induced-nephrotic syndrome in rats has been demonstrated to be associated with a marked reduction in the expression levels of three aquaporins and the vasopressinregulated urea transporter in the collecting duct system. These decreases in the protein expression appear to be relatively selective, and are most likely associated with the nephrotic syndrome per se rather than the drugs used to induce the nephrotic syndrome. These changes may represent an appropriate kidney response to the extracellular volume expansion observed in nephrotic syndrome.
